Craig L. Leonardi - Concepedia

Author

Craig L. Leonardi

Saint Louis University

Also Known As

Craig L Leonardi, Craig L. Leonardi, Craig L. Leonardi, MD, Craig Leonardi, Kenneth B. Gordon, Sunil Dhawan

179

Publications

21.2K

Citations

H-Index

Concepts

All Affiliations

Saint Louis University Central Dermatology Icahn School of Medicine at Mount Sinai Oregon Medical Research Center Probity Medical Research

About

Craig L. Leonardi is an author at Saint Louis University specializing in medicine, dermatology, and psoriatic arthritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	36	9.8K
2	Public Health	3	3	69
3	Epidemiology	2	2	25
4	Health Sciences	1	1	1.1K
5	Health Policy	1	1	15

Craig L. Leonardi

Publications

17.5K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1) Craig L. Leonardi, Alexa B. Kimball, Kim Papp, The Lancet 76-Week ResultsImmunologyClinical TrialsClinical DermatologyPhoenix 1	2008	1.9K
Guidelines of care for the management of psoriasis and psoriatic arthritis Alan Menter, Alice B. Gottlieb, Steven R. Feldman, Journal of the American Academy of Dermatology RheumatologyMedicineClinical DermatologyDermatologyPsoriatic Arthritis	2008	1.2K
Etanercept as Monotherapy in Patients with Psoriasis Craig L. Leonardi, JEROLD L. POWERS, Robert Matheson, New England Journal of Medicine	2003	1.2K
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial Stephen K. Tyring, Alice B. Gottlieb, Kim Papp, The Lancet PsychiatryMedicineClinical TrialsDepressionClinical Dermatology	2005	1.1K
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis Craig L. Leonardi, Robert Matheson, Claus Zachariae, New England Journal of Medicine	2012	927
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis Kim Papp, Craig L. Leonardi, Alan Menter, New England Journal of Medicine	2012	923
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial Alan Menter, Stephen K. Tyring, Kenneth B. Gordon, Journal of the American Academy of Dermatology Autoimmune DiseaseSystemic TreatmentSevere PsoriasisPhase Iii TrialClinical Trials	2007	869
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis Kenneth B. Gordon, Andrew Blauvelt, Kim Papp, New England Journal of Medicine	2016	818
A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis Gerald G. Krueger, Richard G. Langley, Craig L. Leonardi, New England Journal of Medicine	2007	780
Guidelines of care for the management of psoriasis and psoriatic arthritis Alice B. Gottlieb, Neil J. Korman, Kenneth B. Gordon, Journal of the American Academy of Dermatology RheumatologyMedicineClinical DermatologyDermatologyPsoriatic Arthritis	2008	763

Page 1